311 filings
Page 8 of 16
8-K
fcul s6bbcwqfrt
25 May 18
Oragenics, Inc. and Texas A&M University System Granted U.S. Patent for Lantibiotic MU1140
4:10pm
8-K
k79e6q0 j35
10 Apr 18
Oragenics, Inc. Announces Pricing of $1.8 Million Registered Direct Offering
12:00am
8-K
fnltd3
19 Jan 18
Material Modifications to Rights of Security Holders
12:00am
8-K
0kyduudx8
8 Jan 18
Oragenics, Inc. Announces Reverse Stock Split
12:00am
8-K
khwu365mdxfu50 va44m
29 Dec 17
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
weq3o2ksvjkh62z5o
20 Nov 17
Other Events
12:00am
8-K
npbehri gc4kre
13 Nov 17
Other Events
12:00am
8-K
5rihecwmwfqg01fq
9 Nov 17
Oragenics Announces Closing of $3.3 Million Preferred Stock Private Placement
12:00am
8-K
8dxtyg 0svv7z
9 Nov 17
Other Events
12:00am
8-K
v73iq2lk44ku10gf2f
1 Aug 17
Termination of a Material Definitive Agreement
12:00am
8-K
jdsckx1
26 Jul 17
Oragenics Announces Completion of Second Closing of $3.0 Million Preferred Stock Private Placement
12:00am
8-K
jxw7841y0
26 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
qi8jn2b4gvkl6qpa
9 Jun 17
Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE MKT Continued Listing Standard
12:00am
8-K
of4z4w0 fy3v76k1
11 May 17
Oragenics Announces $3.0 Million Preferred Stock Private Placement
12:00am
8-K
vzelisnxi1n t04xnmbp
5 May 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
etwfdsbd t1ta5
18 Apr 17
Entry into a Material Definitive Agreement
12:00am
8-K
alqnybbq
31 Jan 17
Regulation FD Disclosure
12:00am
8-K
qj2adh
13 Jan 17
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
8h95tnd
21 Nov 16
U.S. FDA Grants Fast Track Designation for the Development of Oragenics’ AG013 for Oral Mucositis
12:00am
8-K
v5076j774 xvhm5fy
15 Sep 16
Entry into a Material Definitive Agreement
12:00am